Search results for: NICE
Filter search results
OHE and ABPI Webinar: New EQ-5D-5L value sets for England and the UK and Implications for HTA
11 July 2016
…instrument recommended by the National Institute for Health and Care Excellence (NICE) for use in estimating Quality Adjusted Life Years (QALYs) in cost effectiveness analysis. It is accompanied by a…
OHE at ISPOR Europe 2016: Risk-sharing, Differential Pricing, the Cancer Drugs Fund, and Patient Reported Outcomes
26 October 2016
…Excellence (NICE) and were not routinely available within the NHS in England. After a consultation process, it was agreed that from July 2016, NICE will appraise all new licenced cancer…
25 Years of the Cost Effectiveness Acceptability Curve
30 December 2019
…25 years. She noted that “the substantial impact of the paper is also clear from its inclusion in methods guidelines, including NICE’s methods for technology assessment and in the recommendations…
The Expanding Value Footprint of Oncology Treatments
1 May 2014
…treatment regimen, or patient population or subpopulation. The decisions of three entities were included in the study: the Haute Autorité de Santé (HAS) in France, NICE in England and Wales,…
Incorporating Multiple Criteria in HTA: Methods and Processes
1 March 2011
…such decisions, by NICE in the UK and by similar bodies elsewhere. Other… What a health care system should pay for depends, of course, on the health gain that results….
Doctors, Economics and Clinical Practice Guidelines: Can they be brought together?
1 January 1999
…creation of the National Institute for Clinical Excellence (NICE), the National Service Frameworks,… The topic I have been asked to address, ‘Doctors, Economics and Clinical Practice Guidelines: Can they be…
Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
4 January 2016
…Care Excellence (NICE) to decide which new medicines to recommend for use in… This report details the views of a selection of experts in the fields of health and welfare…
OHE’s AMR consultation response
21 November 2023
…be compensated independent of the volume of sales (Rex and Outterson, 2016). In the UK, the NICE-NHS England Antimicrobial Resistance (AMR) Pilot (NICE, 2023) tested the application of this type…
Giving Priority to the Severely Ill: Social Preferences and Value Based Assessment
30 January 2014, 12:00am
…to the sickest patients. The paper is intended to inform the proposed changes to NICE’s methods in 2014, potentially replacing the existing system of QALY multipliers for end-of-life patients with…